相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fumarase-deficient Uterine Leiomyomas An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings
Wesley J. Harrison et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Two Subtypes of Atypical Leiomyoma: Clinical, Histologic, and Molecular Analysis
Julianne M. Ubago et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
Kati Kampjarvi et al.
BRITISH JOURNAL OF CANCER (2016)
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers
Miika Mehine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
Netta Makinen et al.
PLOS GENETICS (2016)
Uterine Fibroids
Elizabeth A. Stewart
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)
Petr Martinek et al.
VIRCHOWS ARCHIV (2015)
Uterine Leiomyomas With Bizarre Nuclei
Sabrina Croce et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Genomics of uterine leiomyomas: insights from high-throughput sequencing
Miika Mehine et al.
FERTILITY AND STERILITY (2014)
Mutations in Exon 1 Highlight the Role of MED12 in Uterine Leiomyomas
Kati Kampjarvi et al.
HUMAN MUTATION (2014)
Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas
Sana Alsolami et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2014)
Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry
Carolina Reyes et al.
MODERN PATHOLOGY (2014)
Atypical Leiomyomas of the Uterus A Clinicopathologic Study of 51 Cases
Amy Ly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
MED12 exon 2 mutations in histopathological uterine leiomyoma variants
Netta Makinen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours
Akiko Matsubara et al.
HISTOPATHOLOGY (2013)
Characterization of Uterine Leiomyomas by Whole-Genome Sequencing
Miika Mehine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The estimated annual cost of uterine leiomyomata in the United States
Eden R. Cardozo et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors
Eun Mi Je et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups
Dominique Nadine Markowski et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases
R. Koivisto-Korander et al.
MATURITAS (2012)
Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas
Megan M. McGuire et al.
PLOS ONE (2012)
MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
Gaelle Perot et al.
PLOS ONE (2012)
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
Chiara Bardella et al.
JOURNAL OF PATHOLOGY (2011)
MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
Netta Makinen et al.
SCIENCE (2011)
Understanding cellular leiomyomas: a case-control study
F. Andrei Taran et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
Vera M. Abeler et al.
HISTOPATHOLOGY (2009)
Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas
Khush R. Mittal et al.
MODERN PATHOLOGY (2009)
Succination of protein thiols during adipocyte maturation - A biomarker of mitochondrial stress
Ryoji Nagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas
Khush Mittal et al.
GYNECOLOGIC ONCOLOGY (2007)
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology and End Results program, 1978-2001: an analysis of 26,758 cases
Jorge R. Toro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma
Peng Zhang et al.
HUMAN PATHOLOGY (2006)
Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features
NC Christacos et al.
GENES CHROMOSOMES & CANCER (2006)
Increased risk of cancer in patients with fumarate hydratase germline mutation
H. J. Lehtonen et al.
JOURNAL OF MEDICAL GENETICS (2006)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma
AA Sandberg
CANCER GENETICS AND CYTOGENETICS (2005)
The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital
TA Dinh et al.
GYNECOLOGIC ONCOLOGY (2004)
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors
R Lehtonen et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
DD Baird et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)